Crisis Interventions for Pediatric Providers - Autism Version (NCT07508436) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Crisis Interventions for Pediatric Providers - Autism Version
United States70 participantsStarted 2026-12-01
Plain-language summary
The goal of this clinical trial is to examine the initial feasibility, acceptability, and effectiveness of Crisis Interventions for Pediatric Providers - Autism version (CIPP-A) for providers serving autistic youth in outpatient settings. The main question aims to answer:
* Assess whether CIPP-A is feasible and acceptable to providers in development behavioral pediatric clinics?
* Assess whether CIPP-A shows initial effectiveness in increasing providers confidence in managing suicide risk in autistic youth?
If there is a comparison group: Researchers will compare CIPP-A to general safety planning intervention (SPI) on feasibility, acceptability, and initial effectiveness.
Participants will be randomized to receive training in SPI or CIPP-A and complete online surveys and interviews over 6-months to measure feasibility, acceptability, and initial effectiveness.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Pediatric healthcare providers serving autistic youth in a DBP clinic in the U.S.
* Willing and able to participate in the study and its activities, including remote training in either SPI or CIPP-A (depending on randomization)
* Willing and able to provide informed consent
* Comfortable speaking or communicating in English
Exclusion Criteria:
* Pediatric healthcare providers not serving autistic youth
* Pediatric healthcare providers not practicing in a DBP clinic in the U.S.
* Unwilling and unable to participate in the study and its activities
* Unwilling and unable to provide informed consent
* Not comfortable speaking or communicating in English
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Feasibility: Number of times that providers use SPI or CIPP-A in 6 months
Timeframe: Baseline to 6 months
2
Acceptability: Acceptability of Intervention Measure
Timeframe: Baseline to 6 months
3
Initial Effectiveness: Providers confidence in using SPI or CIPP-A